- NYSE:JNJ gains 0.28% on Monday to outpace the broader markets on another bearish day.
- Johnson & Johnson continues to rebound from the widespread pause of its COVID-19 vaccine.
- The pharmaceutical conglomerate is set to announce Q1 earnings on April 20th
NYSE:JNJ has had an uncharacteristically eventful week after making global headlines following some rare side effects from its COVID-19 vaccine. On Monday, Johnson & Johnson actually gained 0.28% to close the first trading day of the week at $162.69, amidst another red day for the S&P 500. Shares of Johnson & Johnson have struggled over the past year, and although the stock remains above both its 50-day and 200-day moving averages, JNJ has lagged the S&P 500 index by over 40% during the past 52-weeks.
Stay up to speed with hot stocks' news!
Johnson & Johnson found themselves at the center of a global controversy last week, as its COVID-19 vaccine was reported to have caused a rare form of blood clots in six patients. The delivery of the vaccine was halted around the world, including in Europe, South Africa, and the United States. JNJ’s goal of 100 million vaccine deliveries to the United States by the end of May could be at risk now, although many believe that the FDA and CDC will soon lift the pause in order to continue towards attaining herd immunity. In all, only about one in every million doses of Johnson & Johnson’s vaccine resulted in the rare blood clots so far.
JNJ Stock dividend
Johnson & Johnson is set to report its Q1 earnings report on Tuesday, and investors have no reason to believe it won’t be another stellar quarter from one of the largest companies in the world. JNJ currently pays a generous 2.49% dividend yield to shareholders, and with over 50 consecutive years of the company raising its dividends, it represents one of the best long-term investments available to investors.
Information on these pages contains forward-looking statements that involve risks and uncertainties. Markets and instruments profiled on this page are for informational purposes only and should not in any way come across as a recommendation to buy or sell in these assets. You should do your own thorough research before making any investment decisions. FXStreet does not in any way guarantee that this information is free from mistakes, errors, or material misstatements. It also does not guarantee that this information is of a timely nature. Investing in Open Markets involves a great deal of risk, including the loss of all or a portion of your investment, as well as emotional distress. All risks, losses and costs associated with investing, including total loss of principal, are your responsibility. The views and opinions expressed in this article are those of the authors and do not necessarily reflect the official policy or position of FXStreet nor its advertisers. The author will not be held responsible for information that is found at the end of links posted on this page.
If not otherwise explicitly mentioned in the body of the article, at the time of writing, the author has no position in any stock mentioned in this article and no business relationship with any company mentioned. The author has not received compensation for writing this article, other than from FXStreet.
FXStreet and the author do not provide personalized recommendations. The author makes no representations as to the accuracy, completeness, or suitability of this information. FXStreet and the author will not be liable for any errors, omissions or any losses, injuries or damages arising from this information and its display or use. Errors and omissions excepted.
The author and FXStreet are not registered investment advisors and nothing in this article is intended to be investment advice.
Recommended content
Editors’ Picks
GBP/USD remains offered near 1.2960 on USD buying
The widespread strength of the US Dollar, paired with the Bank of England's cautious economic outlook, is keeping the British pound in check, leaving GBP/USD hovering defensively near 1.2960.
EUR/USD bounces off lows near 1.0810
The US Dollar is now easing some of its recent rebound, giving risk assets some room to breathe and pushing EUR/USD back to the 1.0850 level on Thursday.
Gold remains offered around the $3,030 zone
After hitting a record high above $3,050 early Thursday, Gold retraced to the $3,030 region amid the stronger Dollar and diminishing US yields, all amid investors' repricing of the latest FOMC event.
Trump calls for US Dollar dominance, vows to make America a crypto superpower in historic crypto summit speech
US President Donald Trump made history as the first sitting President to speak at a crypto summit and addressed investors, traders, institutions and the industry at the event. Trump touched upon key crypto victories of his administration, the recent White House Crypto Summit and his future plans for the industry.
Tariff wars are stories that usually end badly
In a 1933 article on national self-sufficiency1, British economist John Maynard Keynes advised “those who seek to disembarrass a country from its entanglements” to be “very slow and wary” and illustrated his point with the following image: “It should not be a matter of tearing up roots but of slowly training a plant to grow in a different direction”.
The Best brokers to trade EUR/USD
SPONSORED Discover the top brokers for trading EUR/USD in 2025. Our list features brokers with competitive spreads, fast execution, and powerful platforms. Whether you're a beginner or an expert, find the right partner to navigate the dynamic Forex market.